Ramaswamy Anuradha, Puchalski Jonathan
Section of Pulmonary, Critical Care and Sleep, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
J Thorac Dis. 2018 Apr;10(4):2519-2527. doi: 10.21037/jtd.2018.02.72.
Emphysema causes significant morbidity and mortality, incurring both financial and psychosocial costs. Alternatives to medical therapy and surgical lung volume reduction surgery (LVRS) have increased interest in bronchoscopic techniques. Bronchoscopic lung volume reduction (BLVR) is still in its infancy and additional trials and follow-up are critical. However, several new randomized clinical trials (RCTs) have demonstrated improvement in lung function, quality of life and exercise capacity in select patients receiving endobronchial valves and coil therapy. This article highlights recent data regarding bronchoscopic treatment of emphysema.
肺气肿会导致严重的发病率和死亡率，产生经济和社会心理成本。除了药物治疗和外科肺减容手术（LVRS）之外，其他方法也提高了人们对支气管镜技术的兴趣。支气管镜肺减容术（BLVR）仍处于起步阶段，更多的试验和随访至关重要。然而，几项新的随机临床试验（RCT）表明，在接受支气管内瓣膜和线圈治疗的特定患者中，肺功能、生活质量和运动能力有所改善。本文重点介绍了有关支气管镜治疗肺气肿的最新数据。
